Literature DB >> 22727125

Developing a porcine model for study of vocal fold scar.

Gayle Woodson1.   

Abstract

The porcine larynx is very similar in size and structure to that of humans, and wound healing in pigs is very similar to that of humans. However, the pig is not often used in vocal fold scar research because it is difficult to view the vocal folds endoscopically. To further assess the pig as a model for studying vocal scar, we compared the plane of surgical dissection in the mucosa of four porcine vocal folds with that in eight human cadaver larynges. The plane of dissection was quite similar in porcine and human larynges, occurring within the loose layer of the superficial lamina propria. We also compared healing of porcine vocal folds after elevation and replacement of an epithelial flap versus excision of epithelium, leaving an open wound. After 6 weeks, larynges were harvested for histologic examination. There was no significant difference between the mucosa of the normal vocal fold and that of the healed microflap. However, after healing of epithelial excision, there was a depressed scar, with average lamina propria thickness of 302 μm versus 864 μm for the normal fold (P<0.05). Finally, to document that the mucosal wave can be evaluated in the porcine larynx, we developed a preparation that removes the false vocal folds, to allow ex vivo phonation. Experimentally created scar in the porcine larynx is a favorable model for the study of vocal fold healing and for assessment of treatments for vocal fold scar.
Copyright © 2012 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22727125     DOI: 10.1016/j.jvoice.2012.03.003

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  9 in total

1.  MERS versus Standard Surgical Approaches for Porcine Vocal Fold Scarring with Adipose Stem Cell Constructs.

Authors:  Joo Hyun Woo; Suzanne N King; Henry Hoffman; Seth Dailey; Sarah Wang; Michael B Christensen; Susan L Thibeault
Journal:  Otolaryngol Head Neck Surg       Date:  2016-05-10       Impact factor: 3.497

2.  A mixed-effects model approach for the statistical analysis of vocal fold viscoelastic shear properties.

Authors:  Chet C Xu; Roger W Chan; Han Sun; Xiaowei Zhan
Journal:  J Mech Behav Biomed Mater       Date:  2017-08-04

3.  Cigarette Smoke Exposure to Pig Larynx in an Inhalation Chamber.

Authors:  Xinxin Liu; Allison Mustonen; Wei Zheng; M Preeti Sivasankar; Abigail C Durkes
Journal:  J Voice       Date:  2018-07-05       Impact factor: 2.009

4.  In vivo investigation of acidified pepsin exposure to porcine vocal fold epithelia.

Authors:  Abigail Durkes; M Preeti Sivasankar
Journal:  Laryngoscope       Date:  2015-07-07       Impact factor: 3.325

Review 5.  Tissue engineering-based therapeutic strategies for vocal fold repair and regeneration.

Authors:  Linqing Li; Jeanna M Stiadle; Hang K Lau; Aidan B Zerdoum; Xinqiao Jia; Susan L Thibeault; Kristi L Kiick
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

Review 6.  Bioreactors for Vocal Fold Tissue Engineering.

Authors:  Ana M Gracioso Martins; Andreea Biehl; Daphne Sze; Donald O Freytes
Journal:  Tissue Eng Part B Rev       Date:  2021-03-17       Impact factor: 6.389

7.  Hydration State and Hyaluronidase Treatment Significantly Affect Porcine Vocal Fold Biomechanics.

Authors:  Chenwei Duan; Julian M Jimenez; Craig Goergen; Abigail Cox; Preeti M Sivasankar; Sarah Calve
Journal:  J Voice       Date:  2021-02-01       Impact factor: 2.300

8.  The histological components of the phoniatrical body-cover model in minipigs of different ages.

Authors:  Anja Lang; Rüdiger Koch; Karl Rohn; Hagen Gasse
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

9.  Magnetic resonance imaging quantification of dehydration and rehydration in vocal fold tissue layers.

Authors:  Renee E King; Kevin Steed; Ana E Rivera; Jonathan J Wisco; Susan L Thibeault
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.